Contemporary approaches to in-transit melanoma

Jennifer A. Perone, Nellie Farrow, Douglas Tyler, Georgia M. Beasley

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

In-transit melanoma represents a distinct disease pattern of heterogeneous superficial tumors. Many treatments have been developed specifically for this type of disease, including regional chemotherapy and a variety of directly injectable agents. Novel strategies include the intralesional delivery of oncolytic viruses and immunocytokines. The combination of intralesional or regional chemotherapy with systemic immune checkpoint inhibitors also is a promising approach. In the current review, we examine the general management of the workup of patients with in-transit disease, the range of available therapies, and recommendations for specific therapies for an individual patient.

Original languageEnglish (US)
Pages (from-to)292-300
Number of pages9
JournalJournal of Oncology Practice
Volume14
Issue number5
DOIs
StatePublished - May 1 2018
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Oncology(nursing)
  • Health Policy

Cite this